Symposia: Allogeneic Transplantation: Disease Response and Comparative Treatment Studies
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
adult, Biological therapies, Research, Lymphoid Leukemias, Acute Myeloid Malignancies, ALL, AML, clinical trials, Bone Marrow Failure Syndromes, Inherited Marrow Failure Syndromes, Lymphomas, Translational Research, epidemiology, Chimeric Antigen Receptor (CAR)-T Cell Therapies, B Cell lymphoma, Clinical Research, health outcomes research, Diseases, Therapies, aggressive lymphoma, real-world evidence, Adverse Events, Lymphoid Malignancies, registries, Myeloid Malignancies, survivorship, Study Population, Human, Transplantation, Minimal Residual Disease
Type: Oral
Hematology Disease Topics & Pathways:
adult, Biological therapies, Research, Lymphoid Leukemias, Acute Myeloid Malignancies, ALL, AML, clinical trials, Bone Marrow Failure Syndromes, Inherited Marrow Failure Syndromes, Lymphomas, Translational Research, epidemiology, Chimeric Antigen Receptor (CAR)-T Cell Therapies, B Cell lymphoma, Clinical Research, health outcomes research, Diseases, Therapies, aggressive lymphoma, real-world evidence, Adverse Events, Lymphoid Malignancies, registries, Myeloid Malignancies, survivorship, Study Population, Human, Transplantation, Minimal Residual Disease
Saturday, December 10, 2022: 2:00 PM-3:30 PM
391-392
(Ernest N. Morial Convention Center)
Moderators:
Raynier Devillier, Institut Paoli Calmettes
and
Sunita Nathan, MD, Rush University Medical Center
Disclosures:
Devillier: astellas: Honoraria; sanofi: Honoraria; jazz pharmaceutical: Honoraria; medac: Honoraria.
This session will present results from real world studies based on database registry, including large series of rare diseases. In addition, prospective innovative transplantation modalities will be compared to real world data of standard allogeneic transplantation.
2:00 PM
2:15 PM
2:30 PM
2:45 PM
3:00 PM
3:15 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH